Site Map

PPA Causes Stroke Injuries

"The Food and Drug Administration (FDA) is taking steps to remove phenylpropanolamine (PPA) from all drug products and has requested that all drug companies discontinue marketing products containing PPA.  In addition, FDA has issued a public health advisory concerning phenylpropanolamine hydrochloride. This drug is an ingredient used in many over-the-counter (OTC) and prescription cough and cold medications as a decongestant and in OTC weight loss products.

   Scientists at Yale University School of Medicine recently issued a report entitled "Phenylpropanolamine & Risk of Hemorrhagic Stroke:   Final Report of the Hemorrhagic Stroke Project."   This study reports that taking PPA increases the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women.  Men may also be at risk.  Although the risk of hemorrhagic stroke is very low, FDA recommends that consumers not use any products that contain PPA."

       Phares Heindl is a former Chemical Engineer and  Board Certified Civil trial lawyer with over twenty years experience. For a free evaluation of your case email inquiry@Heindllaw.com .

    Click for FDA website source          

              Click For FDA listing of products containing PPA

              Click and serarch American Pharmeceutical Assocaiation Website

              If you would like to discuss your case  contact or email us, inquiry@heindllaw.com